Both in Pharmaceuticals
BioMarin Pharmaceuticals vs Madrigal Pharmaceuticals
Over the past year BMRN returned +10.8% and MDGL returned +15.0%; their daily moves had a correlation of 0.26.
BMRN +10.8% MDGL +15.0%Growth of $1, one year, split-adjusted
| Metric | BMRN | MDGL |
|---|---|---|
| Price | $59.87 | $509.44 |
| Market cap | $11.59B | $11.77B |
| Today | +0.69% | −1.47% |
| 1 month | −7.4% | −4.6% |
| 6 months | +9.3% | +0.8% |
| Year to date | +0.7% | −12.5% |
| 1 year | +11.2% | +20.1% |
| Revenue growth (YoY) | +19.9% | +71.2% |
| Gross margin | 79.5% | 100.0% |
| Net margin | 4.5% | −15.9% |
| P/E (TTM) | 158.8× | — |
| Price / sales | 3.4× | 9.2× |
| Net cash | -$3.31B | $498.0M |
| Dividend yield | — | — |
| Volatility (60d) | 29.6% | 41.3% |
| Short % of float | 5.2% | 13.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).